Pharmaceutical Technology on MSN
High-dose biologic delivery to become industry standard
As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback